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In the last few decades, Moringa oleifera, a multipurpose medicinal plant (MMP) has received 
increased research attention and commercial interest for its nutritional, therapeutic and 
pharmacological properties. Rigorous approaches including biological assays, animal and 
clinical trials are required towards safe usage as herbal therapy. We conducted a systematic 
review of the known pharmacological activities, toxicity, and safety of M. oleifera, usually 
used locally in the treatment and prevention of myriads of illnesses. Five major bibliographic 
databases (SCOPUS, Web of Science, Science Direct, PubMed, and Mendeley) were searched for 
studies reported on pharmacological activities, toxicity, and safety assessment of M. oleifera in 
the last 29 years (1990 – 2019). Studies on animals and humans involving aqueous leaf extracts 
and different preparations from M. oleifera seed and bark were also considered. All articles 
retained, and data collected were evaluated based on the period of the article, country where such 
studies were conducted and the document type. Our search results identified and analyzed 165 
articles while 63 studies were eventually retained. Diverse pharmacological activities including 
neuroprotective, antimicrobial, antiasthmatic, anti-malaria, cardioprotective, antidiabetic, 
antiobesity, hepatoprotective and cytotoxic effects, amongst others, were recorded. Toxicity 
studies in animal models and few human studies showed that M. oleifera is safe with no adverse 
effect reported. The importance of the plant is highlighted in the search for new bioactive 
compounds to explore its therapeutic potentials towards drug discovery and development in 
the pharmaceutical and allied industries.
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Introduction
Multi-purpose medicinal plants (MMPs) have continued 
to elicit research interest and commercial attention 
globally as natural resources considered rich in nutritional 
and pharmacological properties to treat and cure several 
diseases (1,2). Several medicinal products as multi-
therapeutic agents have been derived from such herbs 
and plants and considered safe for consumption (3,4). 
Reports indicated that less than 30% of sub-Sahara Africa’s 
(SSA) population has access to modern health care and 
pharmaceuticals (5). The other 480 million people in the 
region rely on traditional medicines, mainly from MMPs 
(5,6). The medicinal importance and efficacy of the 
MMPs have been variously associated with the presence 
of antioxidants and polyphenolic compounds (1,7,8). In 
recent years, scientific and commercial efforts are being 
intensified to advance the sustainable utilization of 
natural antioxidants from plants in the food and nutrition 
industry as well as preventive health care (9-12). Over a 
decade ago, the global market worth of medicinal herbs 
was estimated to the tune of US$65 billion and with 
increased usage of up to US$5 trillion by 2025 (5). Thus, 
the relevance of MMPs as a reliable source of nutritive 
food, medicine and pharmacology will continue to elicit 
research interest and commercial attention to producing 
effective pharmaceuticals to combat diseases and 
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infections, particularly in the SSA. Ethnopharmacology 
has proven to be an influential and reliable tool in the 
search for indigenous plant species with medicinal and 
pharmacological properties that can be screened for 
pharmaceuticals toward successful drug discovery and 
development (13-15). The adoption of herbal medicine is 
generally hampered by inadequate knowledge of chemical 
constituents, pharmacokinetics and pharmacodynamics 
(16). Other limiting factors include poor quality control, 
scientific and clinical evidence of their efficacy and 
effectiveness (17,18). In many African traditional herbal 
remedies, lack of standardization is one of the major 
constraints to their safety and adoption (19).
In this systematic review, we present M. oleifera as one 
of the valuable MMPs globally recognized as a food and 
medicinal plant providing natural supplements for healthy 
living (1,20,21). It is a plant with numerous local utilizations 
with huge pharmaceutical potentials that can be exploited 
for human health benefits (22,23). The multipurpose 
medicinal activities and ethnopharmacological use 
pattern of M. oleifera have been reported from many 
cultures around the world to treat and cure many illnesses 
like high fever, diabetes, hypertension, sickle cell anemia 
and cancer, among others (24-26). Several authors have 
also reported various bioactivity and pharmacological 
mechanisms of M. oleifera parts including leaf, root, seed, 
and barks (1,27-30). The hypocholesterolemic activity 
has been demonstrated in Wistar rats and rabbits (31,32). 
A detailed review of hyperglycemia and dyslipidemia 
activities of the plant has also been published by Mbikay 
(33). Similarly, various parts are widely used in the 
treatment of neurodegenerative illnesses (23,25,34,35). 
Precisely, an avalanche of evidence on pharmacological 
activities has been highlighted in the literature and 
commercial products attributing such rich activities to 
the abundant presence of bioactive molecules including 
antioxidants, flavonoids, quercetin, Moringine among 
others (36-39). 
Globally, there is increased scientific research, 
commercialization, utilization and demand for M. oleifera 
based pharmaceutics and supplements to challenge various 
illnesses and support healthier living. A review of existing 
literature also indicates commensurate studies on animal 
models to support and confirm the pharmacological 
properties and safety of M. oleifera. However, safety 
reports on human studies with no adverse effects are few 
(40). Herbal extracts and products are limited in use and 
adoption probably due to the uncertainty surrounding 
their toxicity level and safety (41). In addition, several 
reports have shown that toxicity studies are necessary 
to validate the safety limits of many herbal preparations 
(42,43). From our observation and market surveys, 
Moringa-based products and supplements are becoming 
increasingly available in the open market, as well as online 
portals without commensurate toxicity assessment tests to 
establish their safe consumption. Also, different degrees 
of toxicity have been reported on various seed extracts of 
M. oleifera and thus requiring more scientific reviews and 
experimental trials (42,44). Hence, this systematic review 
is aimed to update existing information on the overall 
value of the pharmacological activities, toxicity and safety 
potentials of M. oleifera as an MMP.
Methods
Search strategy
We conducted a systematic review on pharmacological, 
toxicity and safety of M. oleifera over a period of 29 years 
(1990 to 2019). Five major databases including PubMed, 
ScienceDirect, Web of Science, Scopus and Mendeley 
were engaged in the course of searching for relevant 
information and data. The search terms were “M. oleifera” 
and (“pharmacological activities”, “safety”) without 
narrowing or limiting search items. Table 1 shows the 
search terms and combinations. For our search strategy, 
the systematic procedure reported by Page and Moher 
(45) was adopted.
Study selection
Article and study selection was based on originality 
of research works, keywords and search terms in the 
title, abstracts and studies involving pharmacological, 
toxicological and safety assessment of extracts of M. 
oleifera. Inclusion criteria were papers that evaluated the 
medicinal and pharmacological properties of M. oleifera 
parts (leaves, seeds, and barks) in the treatment of several 
ailments. We excluded review articles, abstracts, case 
reports and conference proceedings with no link with our 
inclusion criteria. The articles were reviewed for titles and 
abstracts by two reviewers (JOP, OSA) while duplicated 
articles were eliminated. 
Data extraction
One author (JOP) extracted data using standardized 
forms. Publications with available abstracts were reviewed. 





4 2 or 3 
5 1 and 4
6 Safety
7 Toxicity
8 6 or 7
9 5 and 8
*Searches on PubMed, Scopus, Science Direct, and Mendeley, Web of 
Science, followed the same pattern.
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Searched terms and documents were analyzed based on 
period/year of publication, country/territory, document 
type (review papers, research papers, books, etc) and 
subject areas using Excel 2013. The collected information 
included different types of extracts, pharmacological 
compounds, and activities, model experiments (animals: 
rats, mice, clinical trials), the dosage of extracts or drugs 
and the outcomes. Results were measured in terms of 
pharmacological and toxicity activities as well as the safety 
of M. oleifera extracts and other preparations. Publications 
with abstracts on human and animal studies with the main 
outcome as mentioned above were included. All data were 
analyzed and presented in the form of a flowchart, charts, 
tables, and figures. 
Quality assessment
We carefully assessed the pharmacological activities, 
toxicity and safety of M. oleifera with clear case definitions. 
Studies with ambiguous investigations and outcomes were 
excluded. The procedure of Siqueira-Lima et al (46) was 
adopted to assess the quality of clinical trials involving a 
living organism. The studies selected involving random 
treatment distribution, outcome measurements, and 
blinded outcome evaluation were analyzed using Excel 
2013. 
Toxicity and safety studies
Toxicity and safety studies involving animal models 
and human clinical trials were considered based on 
histopathology tests, relative organ weights, and toxicity 
biomarkers. 
Results
After careful searches of databases, we identified and 
selected 165 articles that clearly matched our selection 
criteria out of a total of 618 articles searched. The 
breakdown of the database searches was as follows: 35 
articles out of 52 from Scopus, 55 articles out of 456 from 
ScienceDirect, 50 articles out of 85 from PubMed while 
13 from Web of Science and 12 from Mendeley directly 
related to the purpose of this review were selected. From 
the 165 articles selected, 50 articles duplicated in two or 
more databases were excluded leaving us with 115 articles. 
After preliminary selection of articles based on inclusion 
benchmarks, a total of 63 published articles were carefully 
chosen while others were excluded. The data in Figure 1 
shows the flowchart of our search strategy. Most of the 
studies on pharmacological activities, toxicity, and safety 
on M. oleifera were carried out by experts from Indian, 
Nigeria, South Africa, Italy, Bangladesh, Egypt, Cameroun, 
Malaysia, Iran among others. Source of articles identified 
and selected for this review, articles per database searched, 
year and number of publications as well as geographical 
location and number of publications were illustrated in 
Figure 2. 
Pharmacological activities of Moringa oleifera
Articles resulting from the search provided information 
which revealed a high degree of diversity in the 
pharmacological activities of M. oleifera linked to 
various extracts, fractions, and compounds isolated 
from M. oleifera. Neuroprotective, antimicrobial and 
antiasthmatic, anti-malaria, cardioprotective, antidiabetic 
and antiobesity, as well as cytotoxic activities amongst 
 
     Articles screened = 115 
Duplicated articles 
excluded = 50 
Articles finally retained 
= 63 
Rejected articles = 52 
SCOPUS: 52 
articles searched 
and 35 selected 
ScienceDirect: 456 
articles searched 
and 55 selected 
PUBMED: 85 
articles searched 








Total number of articles searched = 618 
Number selected = 165 articles 
Figure 1. Flowchart of the search strategy and articles included in this review.
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others were recorded (Figure 3). Moringa isothiocyanate 
was variously mentioned and associated with the 
pharmacological activities of M. oleifera. Information in 
Table 2 shows the pharmacological properties included 
in this review, authorship, countries of studies, specific 
investigation and outcomes.
Toxicity and safety of Moringa oleifera
Studies on the toxicity and safety of M. oleifera included 
in this review are shown in Table 3.  Generally, studies on 
the toxic effects and safety have reported of M. oleifera to 
be safe  in various models on mice, rats, rabbits, in vitro 
assays and some clinical trials (42,58-60). In retrospect, 
very few toxicity and safety evaluations were encountered 
in investigations involving humans or clinical trials. 
Sixteen studies were evaluated on quality assessment of 
pharmacological studies of M. oleifera using experimental 
animals. Among the articles retained, above 75% of 
studies reported and mentioned the random distribution 
of animals during experimental procedures. Ten studies 
clearly mentioned sample size while six did not (Figure 
4). From the articles retained, doses tested on the 
experimental subjects showed no adverse effects.
Discussion
Database searches and global relevance of M. oleifera
The outcomes of this systematic review confirm that 
M. oleifera is an important plant species with a plethora 
of pharmacological and therapeutic activities. Our 
data indicate that Indian researchers were the highest 
Figure 2. Source of the articles identified and selected for the systematic review according to (A) articles from the different databases, (B) selected articles 
per database search, (C) year and the number of publications and (D) geographical location and number of publications.
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Table 2. Specific pharmacological properties of Moringa oleifera included in this review
S/N Author Country Specific investigation Findings Pharmacological properties
1 Moura et al (47) Brazil
Evaluated the antimicrobial perspective of water-soluble moringa 
seed lectin on bacteria: Serratia marcescens and Bacillus sp. 
Inhibitory effect against S. marcescens and Bacillus sp. Biofilm 
formation studied
The water-soluble M. oleifera Lectin suppressed the formation of biofilm by the bacteria (S. marcescens), 





2. Jaja-Chimedza et al (48) USA
Comparative studies on the anti-inflammatory activities of 
isothiocyanate-enriched MSE, CTE and CEM
Moringa isothiocyanate-1 of MSE significantly reduced carrageenan-induced paw edema in Sprague-
Dawley rats at a rate comparable to aspirin, whereas CTE had no significant effect. It significantly inhibited 
the gene expression of lipopolysaccharide- iNOS, IL-1β and IL-6 and NO production, whereas, at all the 
concentrations tested, CEM had no significant activity. 
Anti-inflammatory 
and anti-oxidant
3. Omodanisi et al (49)
South 
Africa
Male Wistar rats were induced with STZ and consequently exposed 
to methanolic leaf extract of M. oleifera to evaluate its anti-oxidant, 
inflammatory and hypoglycemic activities. 
A significant reduction in plasma glucose level reported in Moringa treated diabetic rats. The 
hypolipidemic activity was demonstrated in diabetic rats. Antioxidant activity was reported to be high. 
Moringa leaf extract showed a depressing impact on biomarkers-TNF-α and IL-6. Diabetic nephropathy 
was significantly reduced.
4 Cheraghi et al (50) Iran
Cardioprotective property of M. oleifera leaves using isolated N,α-L-
rhamnopyranose VR compound was evaluated in rats induced with 
doxorubicin cardiac toxicity
VR reduced MDA levels in heart tissues. Consequent upon administration, reduced SOD and GSH levels 
were increased. VR administration inhibited the appearance of markers of heart failure. Cardioprotective
5. Giacoppo et al (51) Italy
The study evaluated the antiproliferative properties of M. oleifera 
leaves using isolated isothiocyanate (moringin) complexes on human 
neuroblastoma cells.
The growth of SH-SY5Y cancer cells was suppressed. MAC treated cells displayed a dosage reliant 
downregulation of phosphatidylinositol 3-kinase (P13K)/ Akt (protein kinase B)/ mammalian target of 
rapamycin pathway. MAC treatment also induced apoptotic cell death pathway in the tumor cells.
Anticancer
6. Tiloke et al (52)
South 
Africa
Investigated the anticancer activities of leaf extract of M. oleifera on 
human esophageal Cancer Cell lines
 Leaf extract significantly increased DNA fragmentation and lipid peroxidation in the cancer cells. 
Induction of apoptosis was also observed. 
7. Jaafaru et al (53) Malaysia
Examined the anticancer effect of Moringa-complex compound: 
GMG-ITC-RSE on human prostate cancer cells (PC-3).
Anti-proliferative effects on PC-3 cells were reported while the safety of the Glucomoringin-
isothiocyanate rich soluble extracts was confirmed.
8. Muhammad et al (54) Malaysia
Wound healing abilities of bioactive M. oleifera aqueous fraction on 
STZ and NAD - induced diabetic Wister rats were evaluated.
Antibacterial susceptibility testing revealed that Moringa oleifera aqueous fraction repressed bacteria 
growth on chronic wounds of diabetes (S. aureus, P. aeruginosa, and E. coli). The bioactive fraction of 
Moringa enhanced wound healing in diabetic rats by downregulating proinflammatory cytokines and 
promoting angiogenesis. 
Wound healing
9. Hannan et al (55)
Republic 
of Korea
In vitro neuroprotective potential of M. oleifera ethanolic leaf extract 
evaluated.
Leaf extract dose-dependently increased number, length, and branching of neuritis. Moringa leaf extract 
protected neurons against naturally occurring cell injury by significantly increasing neuronal viability, 
enhanced neuronal differentiation and synaptogenesis.
Neuroprotective
10. Devaraj and Krishna (56) India
Evaluation of the antiulcerative activity of polyherbal concoction 
containing M. oleifera, Raphanus sativus, Amaranthus tricolor leaf 
extract in experimental model of gastric ulcer in male Albino Wister 
rats 
Polyherbal concoction exhibited significant antiulcer activity. Herbal formulation was reported to be 
efficacious in preventing stomach sores caused by reperfusion and ischemia, ethanol and indomethacin.
Antiulcer
11. Manaheji et al (57) Iran
Arthritis-induced rats on CFA were subjected to methanolic leaf and 
root extracts of M. oleifera to evaluate the analgesic properties 
The extracts considerably reduced symptoms of pain, heat and particularly the allodynia and thermal 
hyperalgesia in tested rats with CFA-induced arthritis Analgesic
GMG-ITC-RSE - Glucomoringin-isothiocyanate rich soluble extract, MSE- M. oleifera seed extract, CTE- curcuminoid-enriched turmeric extract, CEM- curcumin-enriched material, VR- vincosamide, CFA - complete Freund’s adjuvant; NAD, 
nicotinamide; STZ, Streptozotocin; iNOS, inducible nitric oxide synthase; NO, nitric oxide; IL, interleukin; TNF, tumor necrosis factor; MDA, malondialdehyde; SOD, superoxide dismutase; GSH, glutathione peroxidase.
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Table 3. Toxicity and safety studies of Moringa oleifera included in this review
S/N Author Country Model experiment Specific investigation Findings
1. Adedapo et al (61) Nigeria Rats
Oral toxicity and safety of M. oleifera leaf extracts were investigated in rats at different 
standards and higher doses administered for 21 days.
No adverse effect on studied organ and organism. The extracts were reported to 
be safe for consumption in tested organisms.
2. Asare et al (20) Ghana Rats and human
The study evaluated the toxicity and safety of an aqueous leaf extract of M. oleifera in 
different rats and human blood cells. The rats were fed with high doses of the extracts at 
1000 and 3000 mg/kg of and observed for two weeks. Outer blood mononuclear cells in 
humans were also subjected to graded doses of the extract. 
No toxicity was recorded at low and standard doses but at a very high dose of 
3000 mg/kg b.wt, the extracts were genotoxic. The dose of 3000 mg/kg was too 
high which exceeded the recommended doses. Thus, at recommended/standard 
doses, no traces of genotoxicity were found both in rat's human cells examined.
3. Jaafaru et al (60) Malaysia Rats and human
Toxicity and antiproliferative actions of M. oleifera glucomoringin-isothiocyanate 
on cellular multiplication and apoptosis in human prostate cancer cells (PC-3) was 
investigated
The glucomoringin-isothiocyanate was found to be non-toxic, induced apoptosis 
and inhibited human cancer cell proliferation.
4 Kim et al (42) USA Rats
Toxicity evaluation to determine the safety of Moringa isothiocyanate-1 -enriched hydro-
alcoholic MSE was investigated in rats. Toxicity was determined in various internal organs 
and cells: gastrointestinal and stomach lesion and discoloration among others.
No mortality was recorded at normal, mid-high and mid-low dose groups. 
However, mortality was observed in group fed with very high doses of the extracts. 
5 Villarruel-Lopez et al (62) Mexico
Sprague Dawley 
rats 
Toxicity and genotoxicity of leaf powder of M. oleifera administered at different doses 
were evaluated in rats using LD50 and micronuclei assay. Different organs were observed 
by the hematoxylin-eosin technique. 
Tested doses were not lethal on experimental rats. Genotoxicity parameter were 
not statistically significant.
6 Chin et al (59) Malaysia Rats
Harmful/toxic studies of M. oleifera extract on the dermal wound on healthy rats were 
carried out and symptoms of toxicity evaluated. STZ/HFD-induced diabetic rat excised with 
abrasion wounds and observed for wound healing for a period of 21 days. 
No signs of dermal toxicities observed on M. oleifera film formations. The in vivo 
dermal toxicity and safety test showed that all film dressings were non-toxic. 
7 Awodele et al (58). Nigeria Mice
The toxic effect of M. oleifera aqueous leaf extracts on mice was evaluated using oral 
administration of 6400 mg/kg extracts and intraperitoneal dose of 1500 mg/kg.  In another 
trial, the mice were orally administered different doses for 60 days. 
No toxicity level recorded on examined organs and cells. The study concluded 
that leaf extracts of M. oleifera were safe in the experimental animals used.  
8 Oyagbemi et al (63). Nigeria Wista Rats
The study investigated the toxicity of M. oleifera methanolic extracts at differing dosages 
in 30 Wistar rats for 2 months. No adverse effect reported
9 Agrawal and Mehta (64)
Clinical trial 
(Human)
Antiasthmatic effect of M. oleifera seed kernels on bronchial asthma of 20 asthmatic 
patients was investigated. Toxicity was also evaluated on the patients No adverse effect reported and that M. oleifera seed kernels were safe. 
MSE, Moringa seeds extract.
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investigators on M. oleifera utilization and exploitation 
followed by those from Nigeria. There was also a steady 
rise in publications from 1991 and to a peak in 2018/2019. 
The high number of articles returned from searches, 
those retained and the spread of articles that cut across 
Africa, Asia, the Middle East, Europe, and America is an 
indication of global research interest on M. oleifera. This 
is unprecedented and comprehensive in recent times. The 
articles were inclusive and detailed enough to understand 
the mechanisms of the pharmacological activities, toxicity, 
and safety of M. oleifera as a herbal source. Scientific 
investigations over the last 29 years on M. oleifera have 
been impressive and substantiated many of the traditional 
folklore claims on the plant. These can be further explored 
for drug development and nutritional enhancement using 
genetic-based approaches and smart-technologies. The 
positive correlation between the intake of M. oleifera-
enriched foods and reduction in the risk of having certain 
types of non-communicable diseases also confirm the rich 
pharmacological properties of the plant (65, 66). Overall, 
the bioactive components in M. oleifera have been well 
researched, isolated and documented to promote good 
health and living (66). This review summarizes the 
pharmacological activities and safety of M. oleifera as a 
reliable source of new drugs in the near future.
Pharmacological activities of M. oleifera
Anti-oxidant and free radical scavenging activities/
properties
A high number of articles retained for the pharmacological 
activities reported the anti-oxidant and free radical 
scavenging activities of M. oleifera. Anti-oxidants are 
usually reducing agents like ascorbic acid, thiols, and 
polyphenols that reduce signs of aging, the risk of heart 
attacks and stroke (44,67). Articles reviewed indicate 
that M. oleifera is rich in antioxidants and phenolics with 
the ability to stabilize free radicals produced in cells to 
tolerate electrons. Recently, the antioxidant activities 
of isothiocyanate-enriched M. oleifera seed extract 
were recommended as good botanical leads to mitigate 
inflammatory-mediated chronic disorders (48). Adedapo 
et al (44) also validated the antioxidant capabilities of M. 
oleifera leaf extracts with the potentials to relieve pains 
without toxic reactions. Several other studies have outlined 
the analgesic, anti-oxidant and free radical scavenging 
capabilities of M. oleifera as a multi-purpose medicinal 
plant (44, 68, 69). The in vitro and ex vivo antioxidant, 
hypolipidaemia and antiatherosclerotic capabilities of M. 
oleifera leave extract have been demonstrated in rats as an 
active therapeutic agent against cardiovascular diseases 
(70,71). Adepoju-Bello et al (72) investigated the in vitro 
antioxidant properties of M. oleifera using 1,1-diphenyl 
-2-picryl hydrazil (DPPH) scavenging assay. The outcomes 
confirmed that, among the different doses used, 50% of 
M. oleifera ethanolic extract at a dose of 300 mg/kg was 
superior with very high antioxidant capabilities, restored 
weight and pronounced hypoglycaemic effect in Wistar 
rats (72). 
Anti-inflammatory and analgesic activities
Over 75% of the articles retained highlighted the anti-
inflammatory and pain relieving activities of M. oleifera 
which also have been associated with the plant’s high 
antioxidants content. We noticed increased investigation 
on the anti-inflammatory, antitumor and anticancer 
abilities of M. oleifera. Inflammation is a multifarious 
biological reaction of vascular cells to detrimental 
stimuli, for instance, pathogenic infections, injured cells 
or irritations (44,73). It is a protecting effort/mechanism 
by which organisms tend to get rid of harmful impetuses 
and initiate the healing process (44). Pain, heat, redness, 
swelling, and loss of functions are some of the usual 
symptoms of acute inflammation (74). Adedapo et al 
(75) validated the antioxidant, anti-inflammatory and 
antinociceptive capabilities of the methanolic extract of 
M. oleifera foliage. The analgesic effects of M. oleifera 
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methanolic leaf and root extracts on induced arthritis in 
rats also established that the extracts considerably reduced 
all the mechanical symptoms of pain and inflammation 
among the studied rats (57). A depressing outcome on the 
inflammatory biomarkers-tumor necrosis factor (TNF-α) 
and IL-6 diabetic nephropathy in streptozotocin-induced 
diabetic male Wistar rats were also observed (76). Thus, 
the analgesic and anti-inflammatory capabilities of M. 
oleifera parts are not in doubt and could be carefully 
explored as a cheap and effective drug source to relieve 
pain and treat inflammation-related disorders. 
Anti-microbial and antiasthmatic activities
Plant-based sources of cheaper, effective and reliable 
antibiotics to combat many human and agricultural 
infectious diseases are gaining scientific attention around 
the world. Findings from this review showed that M. oleifera 
is one of those plant species with proven pieces of evidence 
of abundant antioxidants and antimicrobial capabilities 
(77). Caceres et al (39) investigated the leaves, seeds, barks, 
and roots of M. oleifera against many microorganisms and 
established the anti-microbial effects of the studied M. 
oleifera parts. The presence of 4-(alpha-L-rhamnosyloxy) 
benzyl isothiocyanate (1) and 4-(4’-O-acetyl-alpha-
L-rhamnosyloxy)-benzyl isothiocyanate have been 
implicated in the antimicrobial capabilities of the plant 
(39,78,79). For instance, in the studies of Padla et al 
(78), the bioactive complexes (isothiocyanate 1 & 2) 
screened for antimicrobial capabilities against certain 
microbes were implicated to inhibit the growth of gram-
positive bacteria and other microbes. Elgamily et al (80) 
explored the alcoholic extracts of M. oleifera parts for 
dental antibacterial and antifungal abilities with resultant 
inhibition against Staphylococcus aureus and S. mutans. 
In all the articles retained, isothiocyanate complexes were 
highlighted to be responsible for its antimicrobial activities. 
M. oleifera leaf extracts were also found to be potent 
against infectious diseases caused by multidrug-resistant 
gram-negative bacteria (81). The investigation of Moura 
et al (47) clearly established the antimicrobial capabilities 
of the seed lectins from M. oleifera found to suppress 
the formation of biofilm by S. marcescens and inhibited 
bacterial growth. The lectin also suppressed the growth 
of Bacillus sp. With respect to the antiasthmatic activity 
of the species, a clinical evaluation of seed kernels on 
twenty asthmatic patients indicated its efficacy and safety 
to treat asthma in human clinical trials (64). According 
to the study, alkaloid moringine relaxes bronchioles 
which closely bear a resemblance to ephedrine in action 
and valuable to treat asthma and other related ailments. 
Based on the noticeable reduction in asthma symptoms 
and improved breathing functions of the patients, M. 
oleifera is a very potent herbal source that can be used in 
asthma prevention and treatment. Infectious diseases are 
the main cause of death in teenagers (39,81). It is common 
in developing nations with high mortality being recorded 
every year (81). Consequently, bacteria are increasingly 
becoming resistant to antibiotics as a result of a change 
in response to the use of antibiotics, overuse, and misuse 
(81-83). Antibiotics resistance is currently a leading threat 
in the health sector. The WHO at a recent press conference 
organized to commemorate the 2018 world antibiotics and 
diabetes awareness week in Nigeria cautioned the public 
against the misuse of antibiotics and urged healthy feeding 
as well as physical exercise to combat diabetes (Read more 
at https://www.vanguardngr.com/2018/11/who-cautions-
against-misuse-of-antibiotics). 
Cytotoxicity, neuroprotective and anti-cancer activities
The various dietary and behavioural risks causing cancer 
include indulgence in tobacco and alcohol use, inadequate 
consumption of fruits and vegetables, lack of physical 
activities and obesity. Conventional chemotherapy 
is often characterized by known and unknown side-
effects. Consequently, plant-based alternative drugs 
and remedies are vigorously being explored as possible 
therapeutic agents. Findings from this review show that 
M. oleifera contains rich bioactive compounds which can 
be harnessed in the treatment and management of chronic 
diseases including cancer, HIV/AIDS amongst others 
(84). The antitumor actions of M. oleifera have been 
connected to the two-well characterized phytochemicals 
moringinine and quercetin which reverses tumourigenesis 
(85,86). The recent study of Jaafaru et al (60) provided 
more insight into the neuroprotection activities of M. 
oleifera isothiocyanate against hydrogen peroxide-
induced oxidative stress. The isolated compounds, 4-(α-L-
rhamnopyranosyloxy) benzyl ITC (moringin) complexed 
with alpha-cyclodextrin (moringin + α-CD; MAC), were 
shown to possess antiproliferative capabilities on SH-
SY5Y human neuroblastoma cells (53,60). The nontoxic 
M. oleifera complexes induced apoptosis and inhibited the 
metastasis of cancer cells in man (60). In similar studies, 
isothiocyanate from M. oleifera seeds was demonstrated 
to mitigate hydrogen peroxide-induced cytotoxicity 
and maintained human neuronal cell morphology (53). 
Previous studies have also shown the antioxidants and 
anticancer capabilities of M. oleifera crude and aqueous 
extract with the ability to induce reactive oxygen species 
(ROS) (87,88). In addition, the antiproliferative activities 
on two cancer cells HepG2 (liver carcinoma cell line) and 
MCF7 (breast cancer cell line) confirmed M. oleifera as a 
probable source of cancer therapy (52,89,90). In another 
study, the beneficial effect of root extract of M. oleifera 
was evaluated against beryllium-induced oxidative stress 
in rats (91). The study confirmed that M. oleifera with 
piperine therapy was potent, while the mixture of M. 
oleifera and curcumin was more active and showed better 
therapeutic outcomes. The potential anticancer efficacy 
of the plant using the leaf ethanolic extracts has also 
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been demonstrated in human cancer cells such as breast 
cancer cell type MDA-MB-231, HCT-8 (colorectal) cells 
and A549 lung cancer cells (89, 92). Phytonanoparticles 
of M. oleifera and its potential antiproliferative agents 
against cancer are consistent with the safety reports and 
clinical responses on M. oleifera utilization to treat and 
cure cancer, neuroblastoma and other related diseases 
(64,93,94). Suppression of  tumor growth and induction 
of apoptosis on Ehrlich’s solid tumor implanted mice also 
indicated a reliable anti-tumor/anti-cancer capabilities 
of M. oleifera leaf extracts (95). With the preponderance 
of scientific reports on the cytotoxicity, neuroprotective 
and anticancer capabilities of M. oleifera parts, it is hoped 
that pharmaceutical companies around the globe will step 
in and develop Moringa-based drugs to cure cancer and 
other degenerative diseases.
Anti-diabetic and anti-obesity activities
People around the world have exploited herbal medicine to 
solve their health challenges and ultimately for a healthier 
living (96). Diabetes, being a protracted metabolic malady 
of the endocrine system, is characterized by abnormalities 
in carbohydrates, protein, and fat metabolism (97,98). The 
incidence of diabetes is increasing at an alarming rate with 
the attendant high cost of management/treatment and its 
related complications (96,99-101). In 2012 alone, diabetes 
caused 1.5 million deaths with an increased projection 
estimated in recent years (99,101). Stroke, heart attack, 
overweight, kidney failure, obesity, leg amputation, vision 
loss, and nerve damage are some of the complications of 
diabetes. Obesity in Africa is also on the increase, being 
associated with various medical conditions that may lead 
to death. An imbalance in the intestinal flora is one of the 
main factors related to obesity and metabolic disorders. The 
human gut microbiome undertakes a variety of metabolic 
functions such as the breakdown of complex organic 
substances into easily digestible sources of energy. M. 
oleifera possesses antidiabetic, hypo- and hyperglycemia 
effects (1,102). Consequently, the antidiabetic therapeutic 
effect of M. oleifera has been attributed to its polyphenols 
content to reduce blood glucose and lipids concentration 
after ingestion (96). According to the investigation of 
Abd Eldaim et al (103), M. oleifera leaves aqueous extract 
significantly ameliorated hepatotoxicity and reduced 
hyperglycemia in alloxan-induced diabetic rats. In 
another study designed to demonstrate the efficacy of 
M. oleifera ethanolic extract in rats induced with high-fat 
diet obesity, body weight was significantly reduced in rats 
treated with the extracts (104). Potential hypoglycemic 
activity of phenolic glycosides from M. oleifera seed also 
showed significant therapeutic properties in reducing 
blood pressure, blood sugar and enhancing the immune 
system in humans (105). M. oleifera leaves extract was 
thus confirmed to exhibit hypolipidemic and antiobesity 
potentials with the capacity to protect the body against 
negative effects of high fat diet-induced obesity. 
Numerous non-diabetic and diabetic animal studies have 
demonstrated the antidiabetic effect of M. oleifera leaf 
extracts to reduce plasma glucose levels and increase 
glucose tolerance (29,106,107). A significant decrease in 
the level of plasma glucose was reported in rats having 
diabetes using M. oleifera leaves extract (76). The study of 
Jaiswal et al (107) also established the antidiabetic effect 
of constant consumption of the leaves of M. oleifera as a 
therapeutic means to protect diabetic patients against 
oxidative damage. The leaf preparation of the plant was 
also shown to significantly ameliorate streptozotocin-
induced diabetes milletus in adult rats with the outcome 
of a reduction in biomarkers of diabetes (108). Alejandra 
Sanchez-Munoz et al (109) recently demonstrated the 
effect of M. oleifera extract on supercomplex formation, 
ATPase activity, ROS production, glutathione (GSH) 
level, lipid peroxidation, and protein carboxylation. Their 
findings indicated that hyperglycemia modifies oxygen 
consumption, supercomplexes formation, and increases 
ROS levels of STZ-diabetic rats while M. oleifera treated 
rats were protected against some alterations. Recently, 
Leone et al (110) demonstrated the potential hypoglycemic 
capabilities of the powdered form of the leaves of M. 
oleifera on postprandial blood glucose response on 
Saharawi people living in refugee camps and confirmed 
M. oleifera leaf powder as a possible hypoglycemic herbal 
drug. Several other reports have validated the antidiabetic 
activities of M. oleifera leaf and seed extracts in diabetic 
rats (62,110-112). Overall, M. oleifera leaves were 
confirmed to lower postprandial blood pressure (50). 
Cardioprotective and anti-hypertension activity 
Articles retained on anti-hypertension activities of M. 
oleifera suggest a positive correlation between consumption 
of raw leaves/extracts of M. oleifera and reduction in 
blood pressure of tested animals. Globally, hypertension, 
heart failure, and their associated risk factors have been a 
major cause of death without restriction to age (113) while 
almost half the losses in dialysis patients are ascribed to 
heart disease (114). High blood pressure is a typical 
symptom of hypertension with severe complications 
and increases the risk of heart disease, stroke, and death 
(115,116). Findings of different health interventions by 
the University College Hospital (UCH), Ibadan, Nigeria, 
indicated that hypertension is the commonest disease after 
the age of 40 (117). Management and cure for cardiac arrest 
and hypertension are cumbersome using synthetic drugs 
and usually with side effects. Thus, natural remedies that 
reverse hypertension and lowers high blood pressure are 
being sought after as plausible solutions to cardiovascular 
ailments. In this regard, our review outcome indicates that 
M. oleifera is a good candidate useful to treat hypertension. 
Its parts show cardiac protective effects in spontaneously 
hypertensive rats (115). Several studies have also provided 
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scientific proof in support of ethnopharmacological uses 
of M. oleifera as the antihypertensive plant with strong 
cardiac protective effects (118,119). Cheraghi et al (50) 
investigated the cardioprotective property of M. oleifera 
isolated magnetic hydrogel nanocomposite loaded N,α-L-
rhamnopyranosyl vincosamide (VR) on rats induced with 
doxorubicin cardiac toxicity. It was shown that VR levels 
of malondialdehyde (MDA) and superoxide dismutase 
(SOD) in heart tissues were reduced and heart failure 
biomarkers were inhibited. The studies of Nandave et al 
(120) also highlighted the cardioprotective capabilities 
of M. oleifera in isoproterenol (ISP)-induced model of 
myocardial infarction. Their findings indicated that the 
effects of ISP-induced hemodynamic perturbations and 
a rise in lipid peroxidation were significantly repressed 
when tested organisms treated with M. oleifera extracts. 
The cardioprotective/antihypertension capacities of the 
plant might not be unconnected to the high content of 
antioxidant, antiperoxidative, and myocardial preservative 
activities (130). Previous studies and personal experiences 
of one of us (JOP) also validate the consumption of M. 
oleifera raw leaves or extracts to lower the blood pressure, 
enhance sleep and prevent cardiac arrest (2,24). 
Wound healing and anti-ulcer activities
Wound healing and anti-ulcerative pharmacological 
capabilities of M. oleifera have been severally reported 
and associated with rich phytochemical contents of 
alkaloids and antioxidants (59,77,121,122). Ulcer is one 
of the neglected tropical diseases affecting millions of 
people in many countries of the world (123). It is caused 
by infection with Mycobacterium ulcerans. Valuable 
anti-ulcer, anti-secretory and cytoprotective activities of 
M. oleifera were shown in albino Wistar rats using M. 
oleifera ethanolic root-bark extract, which aligns with the 
preponderance ethnobotanical information on the plant 
(24,122). Studies of Ruckmani et al (124) revalidated the 
anti-ulcerative properties of M. oleifera root and leaves in 
alkali preparation with healing effects. The evaluation of 
polyherbal concoction of M. oleifera, Raphanus sativus 
and Amaranthus tricolor leaf extracts in an experimental 
model of gastric ulcer in male albino Wistar rats also 
confirmed the use of M. oleifera as anti-ulcer therapy (56). 
Their findings concluded that polyherbal concoction 
exhibited significant anti-ulcerative activity, efficacious 
in preventing stomach sores caused by reperfusion and 
ischemia, ethanol and indomethacin. In another study, 
M. oleifera extract was compared with a commonly 
used drug for the ulcer, famotidine, and found out that 
the extract and famotidine significantly reduced the free 
acidity and total acidity of gastric juice (125). Thus, M. 
oleifera preparations, particularly in alkali form, can treat 
and cure ulcers without any adverse effect. The presence 
of both tannins and flavonoids has been implicated for the 
antiulcer activity of M. oleifera (39,125,126). 
Wound healing has been described as a complex 
process of tissue repair in response to injury. It is 
characterized by hemostasis, inflammation, fibroplasia, 
and maturation (121,127). An aqueous fraction from M. 
oleifera was reported to heal wounds on diabetic Wister 
rats induced with STZ and nicotinamide (NAD) (54). 
The study established that M. oleifera aqueous fraction 
inhibited the growth of bacteria associated with chronic 
wounds of diabetes. The bioactive compound Vicenin-2 
was implicated to enhance wound healing in diabetic 
rats by downregulating proinflammatory cytokines and 
promoting angiogenesis (54). Alcoholic preparation 
of M. oleifera leaves was also confirmed as an effective 
therapeutic agent in healing skin wound and improved 
fibroblast proliferation and spread thereby increasing 
wound closure rate (121). 
 
Anti-malaria activities
Malaria is a leading and probably the most upsetting 
infectious disease with an increased incidence of 
mortality in sub-Saharan Africa (128,129). The 
mosquito vector, Plasmodium falciparum, is the cause 
of malaria infection. Though one study indicated that 
there is a decline in malaria in many parts of Africa, the 
estimations are not reliable with many deaths recorded 
recently (130,131). Malaria challenge is compounded 
by widespread resistance to artemisinin combination 
therapies by malaria parasites (132). However, as the 
threat of antimalarial drug resistance increases, persistent 
efforts are also being expended in developing alternative 
therapies coupled with the sustainability of existing 
treatments and control methods. Over the centuries, 
the use of herbal combinations or preparations as active 
antimalarial drugs have been seen as an effective approach 
to treat recurrent malaria infections (133,134). M. oleifera 
in combination with other plants has been actively used 
as antimalarial in many parts of Africa and Asia (2,24). 
For instance, M. oleifera and Gynostemma pentaphyllum 
leaf extracts were combined with Artesunate in mice 
infected with Plasmodium berghei and adjudged effective 
in the treatment of malaria (135). The infected mice 
were subjected to artesunate treatment (6 mg/kg) in 
combination with M. oleifera and G. pentaphyllum using 
standard doses. Their findings showed a significant 
curative effect and high percentage suppression in a dose-
dependent manner. Several other studies have established 
the efficacy of polyherbal preparations containing M. 
oleifera in combination with other plants, which also 
inhibited the growth of P. falciparum. This holds enormous 
potential to serve as an excellent source of herbal drug to 
combat malaria (112,135,136). The crude preparation 
of the plant leaves in aqueous form also demonstrated 
antimalarial activities by suppressing P. berghei ANKA 
infection in mice (137). Very recently, Olawoye et al (138) 
studied the actions of M. oleifera powdered leaves on 
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amodiaquine (AQ) pharmacokinetics in healthy twenty 
human volunteers and established a positive interaction 
between AQ and M. oleifera suggesting a possible 
combinatorial therapy for malaria. The methanolic seed 
extract of M. oleifera also exhibited significant insecticidal 
activities, which could be exploited for integrated pest 
management to control the Anopheles mosquito (139). 
Other activities 
The aphrodisiac effect of M. oleifera is gaining scientific 
attention as a supplement to enhance sexual performance, 
although the precise underlying mechanisms are yet to be 
understood (140). The leaf extracts of M. oleifera inhibited 
6-β-hydroxylation of testosterone with monoamine 
modulation effects, which could help to overcome stress-
induced male sexual dysfunction (140,141). A significant 
correlation between increased sexual urges, erectile 
function, and consumption of M. oleifera methanolic 
leaves extract in rats has been reported and attributed 
to its soluble epoxide hydrolase inhibitory actions (142). 
In many local communities in Africa and elsewhere, M. 
oleifera parts have been used in the fight against HIV/AIDs 
and other viral infections due to its immunostimulatory 
effects (24,143,144). A study on the impact of leaf powder 
of M. oleifera as a supplement administered to patients with 
HIV and on antiretroviral therapy significantly enhanced 
their nutritional intake and boosted their immune system 
(145). Thus, the antioxidants in M. oleifera can be carefully 
utilized to fight free radicals and boost immunity in HIV 
and other related patients.
Toxicity, human studies, and safety of M. oleifera
The study of Reddy et al (146) clearly demonstrated 
the non-toxic nature of M. oleifera bark extracts on 
rats without records of lethality. Adedapo et al (44) 
also reported no adverse effect on studied organs and 
organisms suggesting that M. oleifera could be safe on the 
experimental animals. Likewise, the different tested doses 
on rats showed no lethality and significant differences in 
genotoxicity parameters, thus the study confirmed the 
suitability of M. oleifera as a safe herbal drug (62). Asare et 
al (20) reported that half-maximal lethal dose (LD50) of M. 
oleifera aqueous leaf extract was not toxic and observed 
no changes in the behaviour of the studied rats. In other 
related studies involving the administration of high 
dosages of methanolic extract of the plant in male Wistar 
rats, no toxic reaction or mortality was observed among the 
rats (147). The toxicity of M. oleifera aqueous extract was 
investigated in both acute and subchronic studies where 
mice were orally given an extract of 6400 mg/kg, 250, 
500, and 1500 mg/kg, respectively, and intraperitoneally 
supplied a dose of 1500 mg/kg and found to be safe (58). 
In another toxicity evaluation involving different standard 
doses of M. oleifera methanolic extracts for a period of 
2 months, there was no negative toxicity reaction on the 
liver and kidneys of the tested animals (63). According 
to the findings of the study, all experimental rats fed 
with M. oleifera leaf extract did not show any symptoms 
of genotoxicity; however, there was an increase in body 
weight in a dose-dependent manner. Studies of Asiedu-
Gyekye (148) also established the safety of a single dose of 
5000 mg/kg and an oral dose of 1000 mg/kg of M. oleifera 
in tested rats with no overt adverse effects. Recently, 
the safety of Moringa isothiocyanate-1 enriched hydro-
alcoholic Moringa seeds extract was demonstrated in 
mid-low rats groups without toxic reactions on the organs 
(42). Wang et al (105) reported that phenolic glycosides 
compound 1, 4 and 5 may be developed as new safe 
hypoglycemic drugs from M. oleifera, thus validating its 
safety as a safe therapeutic agent. The therapeutic effect 
of M. oleifera consumption on diabetic rats also indicated 
its possible use and safety as an antidiabetic preparation 
(40,149). Other studies have also reported and confirmed 
the safety of M. oleifera as an herbal drug to treat many 
ailments (59,61,64,148). 
Several trials demonstrating potential benefits for the 
treatment of diabetes, ulcer, and asthma and enhancing the 
immune system of HIV/AIDS patients have been reported 
(56,150). However, very few clinical trials involving the 
safety of different preparations of M. oleifera parts have 
been published. Kushwaha et al (150) studied 30 women at 
post-menopause supplemented daily with 7 g leaf powder 
of M. oleifera for 12 weeks and compared with another 30 
post-menopause women as a control group. There was 
a corresponding increase in biomarkers of antioxidant 
properties showing significant anti-hyperglycemic and 
anti-dyslipidemia activities without toxic effects. Moringa 
leaf powder could have served as an appetite stimulant 
in HIV/AIDS patients, thereby improving their immune 
systems (60). Agrawal and Mehta (64) also investigated 
clinical trial and safety of the seed kernel of M. oleifera to 
treat bronchial asthma and demonstrated that the extracts 
were safe with no adverse effects recorded. Maurya et al 
(151) conducted a clinical trial of M. oleifera stem back 
on 30 patients with urinary tract infection and reported 
its safety in humans with no adverse effects reported on 
the patients. Although genotoxicity at the high dose of 
the supplement was reported in human peripheral blood 
mononuclear cells, such doses greatly exceeded commonly 
used doses as demonstrated by the studies of Asare et al 
(20). However, at recommended doses administered on 
rats, M. oleifera was found to be safe without genotoxicity 
observed in the organs tested. Shreds of evidence from the 
literature and articles retained for this review imply that 
M. oleifera (leaves, stem and bark or whole leaves) could be 
safe for consumption as a vegetable, as well as a therapeutic 
agent to fight diseases and possibly enhance healthy living. 
Combining the rich pharmacological activities with the 
safety of M. oleifera, this systematic review concludes 
that M. oleifera could be further explored in the search 
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for cheaper and safer therapeutic agents against diseases 
especially in Africa and other resource poor nations. 
Conclusion
This review highlighted the multifaceted pharmacological 
potentials and safety of M. oleifera as a multi-purpose 
medicinal plant which can be exploited by man in 
the search for more potent drugs to fight diseases. 
The increased usage and research efforts on the 
pharmacological capabilities of the plant (in vivo, in vitro 
and clinical trials), clearly lend credence to the safety 
reported in many works of literature and cultures. Though 
scientific breakthrough has been recorded on many fronts 
including, identification, isolation, and elucidation of the 
structure of pharmaceutical principles responsible for 
many therapeutic actions of M. oleifera, more research 
efforts are needed to ascertain its safety in humans, as 
well as the safety of current and future potential herbal 
formulations of Moringa origin. Many Moringa products 
are already in the market, which requires quality assessment 
for their safety and consumption. The importance of 
M. oleifera cannot be overemphasized in the search for 
new bioactives that could be harnessed for therapeutic 
potentials, and for exploring future research options to be 
engaged in pharmaceutical and allied companies.
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